RE:RE:RE:RE:80 % of AMco drugs are under 6 pounds..market is at 8 poundsThe Investigation will uncover much. CXR will have to atone for Cinven's price jacks. The new portfolio of 60 drugs, is dead. Wait for the whistle blowers.
GenericAdvocate wrote: cg16 wrote: I wonder if its possible that the CMA does an inquiry and finds no issue with CXR? Would look politically prudent that they addressed the issue from hyped media stories, and then put it to bed. If I were CXR and can defend my pricing strategy, I would welcome a review by CMA. Would definitely take a chunk out of short thesis and be a very positive catalyst to for the stock.
Who was the company brought up in Parliament yesterday that increased a drug by 12,000 %
HAHA. THEY ARE COOOOKKKKKKEEDDDDD.